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ABSTRACT
Synapsins are a family of synaptic vesicle phosphoproteins regulating synaptic 
transmission and plasticity. SYN1/2 genes are major epilepsy susceptibility genes 
in humans. Consistently, synapsin I/II/III triple knockout (TKO) mice are epileptic 
and exhibit severe impairments in phasic and tonic GABAergic inhibition that precede 
the appearance of the epileptic phenotype. These changes are associated with an 
increased strength of excitatory transmission that has never been mechanistically 
investigated. Here, we observed that an identical effect in excitatory transmission 
could be induced in wild-type (WT) Schaffer collateral-CA1 pyramidal cell synapses by 
blockade of GABAB receptors (GABABRs). The same treatment was virtually ineffective 
in TKO slices, suggesting that the increased strength of the excitatory transmission 
results from an impairment of GABAB presynaptic inhibition. Exogenous stimulation 
of GABABRs in excitatory autaptic neurons, where GABA spillover is negligible, 
demonstrated that GABABRs were effective in inhibiting excitatory transmission in 
both WT and TKO neurons. These results demonstrate that the decreased GABA release 
and spillover, previously observed in TKO hippocampal slices, removes the tonic brake 
of presynaptic GABABRs on glutamate transmission, making the excitation/inhibition 
imbalance stronger.
INTRODUCTION
Synapsins (Syns) are a family of synaptic vesicle 
(SV)-associated phosphoproteins that play multiple 
roles in neural development, synaptic transmission and 
plasticity. The Syn family is composed of three gene 
products (Syn I, Syn II and Syn III) that exist in multiple 
splice isoforms. Syns interact with SVs and actin and 
regulate SV trafficking and availability for release at both 
pre- and post-docking steps of exocytosis [1].
Constitutive deletion of one or more Syn genes, 
with the notable exception of the single deletion of 
SYN3, generates a temporal lobe-like epileptic phenotype 
characterized by partial, secondarily generalized tonic-
clonic seizures starting after the first two months of life 
and increasing in severity with age and with the number 
of inactivated Syn genes [2-4] (see [5, 6] for review). 
Rarely spontaneous, seizures are more frequently evoked 
by sudden or novel sensory stimuli and are followed by a 
post-ictal period with typical harmonic oscillations in the 
EEG during which the animal is completely immobile [7-9].
Interestingly, several loss-of-function mutations in 
SYN1 and SYN2 genes have been identified in patients 
suffering of epilepsy and/or autism spectrum disorders (ASD) 
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[10-15] and SYN2 has been identified as one of the highest 
risk epilepsy genes in a wide screen population [16]. To 
confirm the reliability of the mouse knockout (KO) models 
in reproducing the human disease, patients harboring SYN1 
mutations display reflex seizures triggered by sensory stimuli 
(reflex epilepsy; [15]), while Syn I and Syn II KO mice 
display various behavioral traits of ASD [17, 18].
Several studies have attempted to clarify the 
synaptic phenotype of Syn KO mice. In mice, the absence 
of either Syn I or Syn II primarily affects γ-aminobutyric 
acid (GABA) transmission, albeit in a different fashion. 
In hippocampal and cortical neurons of Syn I KO mice, 
synchronous GABA transmission is selectively impaired 
[19, 20] while, in hippocampal slices of Syn II KO mice, 
the asynchronous GABA release is virtually abolished 
[21], resulting a in a marked decrease in tonic inhibition 
[22]. Triple Syn I/II/III KO (TKO) mice recapitulate 
the phenotype of the single Syn I and Syn II KO mice. 
Indeed, in TKO hippocampal slices, an impaired phasic 
GABAergic transmission was accompanied by a parallel 
lower tonic inhibition [4, 23]. This loss-of-function 
phenotype was surprisingly associated with an increased 
strength of excitatory transmission observed in both Syn 
I KO primary autaptic neurons [20] and hippocampal 
slices of TKO mice [23]. Such increase in excitatory 
transmission, together with the impairment of GABAergic 
inputs is at the basis of a strong excitation/inhibition (E/I) 
imbalance that is responsible for epileptogenesis during 
the pre-symptomatic period [23-25].
As Syns act by increasing SV availability and 
facilitating the post-docking stages of release at the nerve 
terminal level [1], the increased basal glutamatergic 
transmission cannot be easily explained as a primary 
synaptic consequence of Syn deletion. Since presynaptic 
GABAB receptors (GABABRs) present on glutamatergic 
terminals and stimulated by extracellular GABA [26] 
are known to negatively modulate glutamate release [27, 
28] and play a role in epileptogenesis (see [29-32] for 
review), we addressed the possibility that the increase in 
excitatory strength is due, al least in part, to a dysfunction 
of the presynaptic GABAB receptor (GABABR)-mediated 
brake on glutamate release. We compared the effects of 
specific GABABR antagonists and agonists ((2S)-3-[[(1S)-
1-(3,4-dichlorophenyl) ethyl] amino-2-hydroxypropyl] 
(phenylmethyl) phosphinic acid (CGP55845) and 
baclofen, respectively) on excitatory synaptic transmission 
and short-term plasticity in hippocampal slices and 
primary hippocampal neurons. We found that the 
glutamatergic phenotype is largely attributable to a lack 
of tonic activation of presynaptic GABABRs because of 
the low extracellular GABA. These findings clarify the 
molecular mechanisms underlying the epileptic phenotype 
observed in TKO mice as well as in humans carrying 
loss-of-function mutations in Syn genes and suggest 
novel therapeutic approaches for the correction of the E/I 
imbalance that triggers epileptogenesis.
RESULTS
Blockade of GABAB receptors is ineffective in 
modulating basal glutamatergic transmission in 
the hippocampal slices from TKO mice
We analyzed evoked release of glutamate from 
Schaffer collaterals to CA1 pyramidal neurons in acute 
hippocampal slices from 1-month-old TKO (i.e. before the 
appearance of the first signs of epilepsy) and in slices from 
age-matched wild type (WT) mice. Schaffer collaterals 
were stimulated at increasing intensities (from 10 to 80 μA) 
and the evoked excitatory postsynaptic current (eEPSC) 
amplitude was plotted against the stimulation intensity.
Consistent with previous results [23], excitatory 
synapses from TKO mice exhibited eEPSCs with higher 
amplitudes in response to the same stimulation intensities 
than excitatory synapses from age-matched WT mice 
(Figure 1A and 1B). Potential mechanisms for the enhanced 
excitatory strength could consist of impaired expression, 
functioning or activation of presynaptic GABABRs that act 
by reducing glutamate release from excitatory terminals 
[27, 31]. Thus, we tested the possibility that the increased 
strength of glutamatergic transmission is a consequence of 
a change in the tonic activation of presynaptic GABABRs 
by extracellular GABA, by applying the specific GABABR 
blocker CGP55845 (5 μM).
Interestingly, while the application of CGP55845 
significantly increased glutamatergic transmission in WT 
slices, particularly at high stimulation intensities (Figure 
1A), it was virtually ineffective in further increasing the 
potentiated glutamatergic transmission of TKO slices 
(Figure 1B). The analysis of the effect of the genotype 
revealed that the GABABR blocker attenuated the 
difference in eEPSC amplitude between WT and TKO 
slices (Figure 1C), as a consequence of the total lack of 
effect of CGP55845 in the TKO background.
These results demonstrate that, in TKO mice, the 
presynaptic GABABR-mediated inhibition of the eEPSC 
is virtually absent, providing a possible explanation for 
the enhancement of excitatory synaptic transmission 
associated with deletion of the three Syn genes.
Enhanced synaptic depression of TKO Shaffer-
CA1 synapses is due to the lack of GABABR 
presynaptic inhibition
We previously demonstrated that when the Schaffer 
collateral pathway is stimulated for 20 s at 20 Hz, WT 
glutamatergic synapses respond to the stimulation with a 
long-lasting facilitation, while TKO excitatory synapses 
show only a transient facilitation followed by a profound 
and sustained depression [23]. Moreover, we have recently 
shown that, in addition to negatively modulating glutamate 
release evoked by single pulses, the activation of presynaptic 
GABABRs boosts synaptic strength during high frequency 
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stimulation, by switching glutamatergic transmission from a 
high to low release probability level [33].
Based on these considerations, the Schaffer 
collateral pathway of WT and TKO mice was 
stimulated with a train of 400 stimuli delivered at 20 
Hz in the presence of CGP55845 (5 μM; Figure 2A). In 
agreement with previous reports [33, 34], the blockade 
of GABABRs had a striking effect on WT glutamatergic 
synapses: facilitation was markedly inhibited, except for 
a very early period in the train, and was replaced by a 
profound depression that, however, had slower kinetics 
than that experienced by TKO neurons (Figure 2B, left 
panel). Strikingly, application of CGP55845 was totally 
ineffective in modulating the response of TKO neurons 
to high frequency stimulation (Figure 2B). This result 
suggests that a lack of GABABR-mediated presynaptic 
inhibition contributes to the sustained synaptic depression 
that characterizes TKO synapses under basal conditions.
The analysis of the effect of genotype in the presence of 
the GABABR blockade (Figure 2C) revealed that the difference 
in the extent of eEPSC depression between WT and TKO 
slices was greatly attenuated, as a consequence of the strong 
depressive effect of CGP55845 in WT slices, as compared to 
its virtual lack of effect in the TKO background (Figure 2B).
When the stimulation frequency was lowered to 0.1 
Hz after the end of the train, the facilitation observed in 
WT untreated slices, as well as the depression displayed 
by CGP55845-treated WT slices, were both short-lasting 
and returned to baseline in 50-60 s (Figure 2D, 2E, left 
panels). A similar kinetics of recovery from depression, 
which was not affected by CGP55845 treatment, was 
observed in TKO slices (Figure 2D, 2E; right panels).
Figure 1: GABABR blockade with CGP55845 modulates evoked eEPSCs at Schaffer collaterals/CA1 pyramidal neuron 
synapses of WT, but not TKO, hippocampal slices. (A, B) Effects of increasing stimulation intensities on eEPSC amplitudes in 
CA1 pyramidal neurons from WT (A) and TKO (B) mice in the absence (black trace/symbols) or presence (red trace/symbols) of 5 µM 
CGP55845. eEPSCs were evoked in pyramidal neurons by electrical stimulation of Schaffer collaterals. The plots show the effects of 
GABABR block by CGP55845 on the eEPSC amplitude in the two genotypes. Data are plotted as mean (± sem) current amplitude versus 
stimulation intensity. Representative eEPSC traces evoked in WT and TKO pyramidal neurons in the absence (black) or presence (red) 
of CGP55845 are reported. (C) Comparison of the mean (± sem) eEPSC amplitude evoked with a 70 μA stimulation as a function of the 
genotype in the absence (left) or presence of CGP55845 (right). Data were analyzed by the unpaired Mann-Whitney’s U-test; *p<0.05; 
**p<0.01. WT: n=9 and n=5; TKO: n=9 and n=5; for vehicle and CGP, respectively.
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Exogenous activation of the GABABRs is 
preserved in Syn I, Syn II or TKO autaptic 
neurons
In principle, a lack of effect of the GABABR 
blockade could be due to either a defective GABABR-
mediated transmission or a ceiling effect produced by the 
Syn mutation that occludes the modulation by GABABRs. 
In turn, a defective GABABR-mediated transmission 
can be due to lack in the expression of GABABRs on the 
presynaptic membrane of excitatory neurons, impaired 
GABABR-linked intracellular signaling or exceedingly low 
extracellular GABA concentrations. To identify the exact 
mechanism, we used primary cultures of hippocampal 
autaptic neurons that, by virtue of their extremely low 
cell density, allow to precisely control the extracellular 
medium [20, 35], thus avoiding paracrine effects of released 
neurotransmitters spilled over from neighboring synapses 
[33]. Excitatory autaptic neurons, held at −70 mV, were 
stimulated at 0.1 Hz for over 2 min to obtain a stable 
baseline before the application of GABABR  active drugs 
(Figure 3A).
To estimate the presence of functional GABABRs 
controlling glutamate release from excitatory autaptic 
terminals, we challenged autaptic neurons with the 
potent and selective agonist baclofen and the specific 
antagonist CGP55845. The latter blocker was tested in the 
presence of 1 μM exogenous GABA to tonically activate 
GABABRs. As previously reported [33], baclofen induced 
an over two-fold decrease in the eEPSC amplitude in WT 
neurons, while the application of CGP55845 in GABA 
dramatically increased eEPSC amplitude (Figure 3A, 
3B). When the same treatment was applied to Syn I KO, 
Syn II KO or TKO autaptic neurons, the effects were 
substantially similar across all genotypes (Figure 3B, 
3C). The results demonstrate that functional GABABRs 
are correctly expressed in Syn KO neurons and that their 
affinity for agonists and intracellular signaling are intact.
Presynaptic GABABRs are known to exert a brake 
on glutamate release by negatively controlling Ca2+ 
influx, presynaptic depolarization and SV availability 
for release (see [30] for review). To fully exploit their 
function, we investigated paired-pulse facilitation, an 
exquisitely presynaptic form of short-term plasticity that 
mainly depends on the initial release probability. In WT 
autapses, baclofen induced a marked, persistent and highly 
significant facilitation in response to the second pulse 
with a significant increase in the paired-pulse ratio (PPR), 
while CGP55845 in the presence of GABA significantly 
decreased PPR. These effects were qualitatively preserved 
across genotypes (Figure 4A-4C). As a decrease in the 
initial release probability is the main drive of facilitation 
and the predominant effect of GABABR activation, the 
data indicate that GABABR signaling is functional in Syn 
KO neurons.
To better define to what extent GABABR signaling 
modulates the quantal parameters of synchronous glutamate 
release, we estimated the readily releasable pool for 
synchronous release (RRP) and the probability of release of 
any given SV in the RRP (Pr) using cumulative amplitude 
analysis. When neurons were challenged with a train of 1.5 
s at 40 Hz (60 action potentials), a significant depression 
of eEPSCs became apparent during the stimulation period 
irrespective of the amplitude of the first current in the train 
(Figure 5A). Accordingly, the cumulative profile of the 
eEPSC amplitude displays a rapid rise followed by a slower 
linear increase reflecting the equilibrium between depletion 
and constant replenishment of the RRP (Figure 5B). The 
graphical extraction of the RRP and Pr from the cumulative 
curves of individual WT neurons showed that the decrease 
in the single eEPSC amplitude induced by GABABRs 
activation with baclofen is due to a marked drop in Pr and a 
slighter, but significant, decrease in RRP, while the increase 
in eEPSC amplitude following blockade of GABABRs 
with CGP55845 in GABA elicited a strong increase in 
Pr accompanied by a slighter, but significant, rise in RRP 
(Figure 5C). Both effects are believed to contribute to the 
opposite effects of baclofen and CGP55845 treatments on 
facilitation, although the changes in Pr are likely to give the 
larger contribution. The three Syn KO genotypes responded 
to the GABABR agonist/antagonist challenge with changes 
in the Pr and RRP that were superimposable to those 
observed in WT neurons (Figure 5D).
The lack of stimulation of presynaptic GABABR 
by extracellular GABA directly contributes 
to the strong depression of glutamatergic 
transmission in TKO neurons
After the demonstration that Syn KO excitatory 
terminals are under the control of functional presynaptic 
GABABRs, we attempted to reproduce in primary autaptic 
cultures the facilitation/depression pattern observed ex-
vivo in acute hippocampal slices of WT and TKO mice. 
Since excitatory autapses are characterized by a higher 
Pr and therefore experience a more intense response to 
high frequency stimulation than excitatory synapses 
in brain slices, depression was induced by a repetitive 
stimulation at 8 Hz lasting 20 s (Figure 6A). Under basal 
conditions, both WT and TKO synapses experienced a 
profound depression after a modest and transient phase 
of early facilitation. Depression was significantly faster 
in TKO neurons. Indeed after 0.5 s, the depression was 
significantly higher in TKO neurons (Figure 6B, right 
panel), while after 20 s the steady-state level was similar 
to that reached by WT neurons (Figure 6B, left panel).
Notably, WT excitatory autapses under basal 
conditions behave strikingly differently from WT 
excitatory synapses of hippocampal slices, showing 
synaptic depression rather than facilitation. To explain 
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Figure 2: GABABR blockade greatly increased depression at Schaffer collaterals/CA1 pyramidal neuron synapses of 
WT, but not TKO, hippocampal slices. (A), (B) Effects of sustained and high frequency stimulation of Schaffer collaterals (20 s 
at 20 Hz) in CA1 pyramidal neurons from WT (left) and TKO (right) mice in the absence (black traces/symbols) or presence (red traces/
symbols) of CGP55845. A sustained facilitation was present in WT mice, which became transient and associated with late depression in the 
presence of CGP. On the contrary, the profound depression following a short-lived facilitation observed in TKO mice was unaffected by 
CGP. Representative traces of eEPSCs in response to the 1st, 2nd and last action potential in the train are shown, normalized to the amplitude 
of the first response (WT, 97.9 pA; WT+CGP, 249.6 pA; TKO, 430.2 pA; TKO+CGP, 408.0 pA) (A). In the main plots, the amplitude of 
eEPSCs, normalized to the mean baseline value is plotted as a function of time (B). (C) Mean (± sem) percentage of depression of eEPSC 
amplitude as a function of the genotype in the absence (left; black bars) or presence of CGP55845 (right; red bars). Quantitative analysis 
of depression was carried out by measuring the first eEPSC 0.5 s after the peak of facilitation (Ip) and 10 s after the start of the train 
stimulation (I10 s), according to the formula: (Ip-I10s)/Ip 
*100 (see panel B). The effects of GABABR block by CGP55845 in the two genotypes 
were analyzed using the unpaired Mann-Whitney’s U-test; *p<0.05; **p<0.01. (D), (E) The time course of recovery, studied for 600 s after 
the end of the train by lowering the stimulation frequency from 20 to 0.1 Hz, is shown for WT (left) and TKO (right) slices in the absence 
(black) or presence (red) of CGP55845. Representative traces of eEPSCs at various times of recovery are shown after normalization to the 
baseline (bsl) amplitudes (WT, 87.5 pA; WT+CGP, 239.4 pA; TKO, 427.1 pA; TKO+CGP, 400.3 pA) (D). In the main plots, the amplitude 
of eEPSCs, normalized to the mean baseline value, is plotted as a function of time (E). *p<0.05, #p<0.05, for untreated and CGP-treated 
samples, respectively; one-tailed paired Student’s t-test vs mean steady-state values calculated in the last 5 min of recording (shaded area). 
WT, n=11 and n=10; TKO, n=6 and n=10; for vehicle and CGP, respectively.
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Figure 3: GABAB receptors are functional in WT, Syn I KO, Syn II KO and Syn TKO hippocampal neurons. (A) 
Representative autaptic eEPSCs recorded in WT, Syn I KO, Syn II KO and TKO hippocampal neurons under control conditions (ctrl; 
black traces) and in the presence of either 20 μM baclofen (Bclf; blue traces) or 5 μM CGP55845 (CGP; red traces). To detect the effects 
of the GABABR block with CGP55845, eEPSCs were recorded in the presence of GABA (1 μM) in the extracellular solution. Currents 
were elicited clamping the cell under study at –70 mV and then by stimulating with a step to +40 mV (0.5 ms at 0.1 Hz, inset). Stimulation 
artifacts were blanked for clarity. (B) Mean (± sem) changes in eEPSC amplitude induced by baclofen and CGP55845. The superimposed 
symbols represent individual eEPSC values before (ctrl or GABA alone) and after treatment with either baclofen (blue bars) or CGP55845 
(in GABA; red bars). Data were analyzed by using the two-tailed paired Student’s t-test; **p<0.01; ***p<0.001. (C) The mean (± sem) effect 
of either baclofen (blue bars) or CGP55845 (in GABA; red bars) on eEPSC amplitude across genotypes, shown in percent of the respective 
effect observed in WT neurons, shows a similar extent of modulation across genotypes. Data, analyzed by one-way ANOVA/Bonferroni’s 
tests, were not significantly different. WT: n=12 and n=11; Syn I KO: n=11 and n=13; Syn II KO: n=11 and n=10; Syn TKO: n= 12 and 
n=11, for Bclf and CGP treatments, respectively.
Oncotarget90067www.impactjournals.com/oncotarget
this apparent discrepancy, we challenged GABABRs 
with baclofen, GABA or CGP55845 to determine which 
of the treatments can mimic the brain slice conditions. 
Application of CGP55845 in the absence of exogenous 
GABA (Figure 6C) left the depression profiles of both WT 
and TKO autapses totally unaffected, confirming that in 
the extremely low-density culturing conditions used for 
growing autaptic neurons GABA spillover from the few 
GABAergic neurons and endogenous GABA levels in the 
medium are negligible. However, when either baclofen 
(Figure 6D) or low concentrations of exogenous GABA 
(1 μM; Figure 6E) were added to activate GABABRs, 
the depression was virtually abolished in both genotypes 
(Figure 6D), recapitulating the facilitation observed in WT 
slices in response to sustained high frequency stimulation 
(see Figure 2). Notably, the addition of CGP55845 after 
pretreatment with exogenous GABA reestablished the 
strong depression present under basal conditions in both 
WT and TKO neurons (Figure 6F).
The comparison between hippocampal slices and 
autaptic neurons strongly indicates that while both WT 
and TKO autaptic excitatory neurons are exposed to very 
low or null concentrations of extracellular GABA, WT 
pyramidal neurons in slices are exposed to a tonic GABA 
stimulation of presynaptic GABABRs that lowers the Pr 
and makes them “facilitating synapses”. On the contrary, 
the very low levels of extracellular GABA in TKO mice 
due to the impaired inhibitory transmission maintain TKO 
pyramidal neurons under a condition of increased Pr, 
due to silent GABABRs that causes the strong depressive 
behavior. Notwithstanding the depleted SV reserve pool 
of TKO terminals, this depressive phenotype was however 
Figure 4: Exogenous activation of GABAB receptors similarly affects short-term plasticity of glutamatergic transmission 
in WT, Syn I KO, Syn II KO and Syn TKO hippocampal autapses. (A) Paired pulse eEPSCs at 50 ms inter-stimulus interval 
were recorded in WT, Syn I KO, Syn II KO and TKO hippocampal autapses under control conditions (ctrl; black traces) and in the presence 
of either 20 μM baclofen (Bclf; blue traces/symbols) or 5 μM CGP55845 (CGP; red traces/symbols). Samples to be challenged with 
CGP55845 were recorded in the presence of 1 μM GABA in the extracellular solution. Representative paired pulse traces (0.1 Hz, inter-
pulse interval 50 ms, inset) are represented without artifact for clarity. (B) The time course of the paired-pulse ratio (PPR), calculated as the 
amplitude ratio between the second to the first response (I2/I1), is shown as means ± sem for the four genotypes during the 10 min treatment 
with either baclofen or CGP55845 (in GABA). (C) Changes (means ± sem) in PPR induced by baclofen and CGP55845 (in GABA) in WT, 
Syn I KO, Syn II KO and TKO neurons before (ctrl) and 10 min after the respective treatment. Data were analyzed by using the two-tailed 
paired Student’s t-test; ***p<0.001. WT: n=9 and n=9; Syn I KO: n=11 and n=11; Syn II KO: n= 10 and n=8; Syn TKO: n=13 and n=13, for 
baclofen and CGP, respectively.
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reversible, as both WT and TKO autaptic neurons exposed 
to physiological concentrations of extracellular GABA or 
challenged with a GABABR agonist switched depression 
into mild facilitation (Figure 6D, 6E).
In summary, our results in acute slices and autaptic 
neurons (see Figures 2B, 2C and 6B, 6F, respectively) 
demonstrate that the lack GABABR-mediated presynaptic 
inhibition caused by the impaired GABA release from 
Figure 5: Presynaptic GABABR activity similarly affects Pr and RRP size in WT, Syn I KO, Syn II KO and Syn TKO 
hippocampal excitatory autapses. (A) Representative recordings evoked using high frequency stimulation (60 stimuli at 40 Hz) in 
autaptic neurons pretreated for 10 min with vehicle (black trace), baclofen (blue trace), GABA (1 μM; gray) or CGP55845 in the presence 
of 1 μM GABA (red trace). All stimulation artifacts were blanked. (B) Representative cumulative profiles of eEPSC amplitude for the 
cells shown in A. Data points in the 0.5-1.4 s window were fitted by linear regression and back extrapolated to time 0 (dashed lines) to 
estimate the RRP size. (C) Mean (± sem) values of the first current pulse of the train, RRP size and Pr for synchronous release estimated 
in WT autapses. For each bar, the superimposed symbols represent individual values before and after the treatments (Bclf n=8, CGP n=6; 
two-tailed paired Student’s t-test with *p<0.05, **p<0.01, ***p<0.0001). (D) Estimation of the changes in quantal parameters induced by 
manipulations of GABABRs in Syn I KO, Syn II KO and Syn TKO autapses under the same conditions of panel C (Syn I KO: Bclf n= 9, 
CGP n=12; Syn II KO: Bclf n= 9, CGP n=6; Syn TKO: Bclf n= 9, CGP n=10; two-tailed paired Student’s t-test with *p< 0.05, **p< 0.01, 
***p< 0.0001).
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inhibitory synapses, worsens depression of TKO excitatory 
synapses, exacerbating the direct effects of defective SV 
trafficking directly caused by Syn deletion.
DISCUSSION
Mutations in the SYN1 and SYN2 genes are 
associated with epilepsy and/or ASD [10, 11, 12, 16] and 
the identification of the pathogenic mechanisms leading to 
the overt clinical manifestations is fundamental to establish 
personalized therapies. Syn I KO, Syn II KO and TKO mice 
are reliable experimental models of the human disease as 
they develop epilepsy starting from 2-3 months after birth 
and display an ASD-like behavior [5, 17, 18]. Previous 
studies in TKO autaptic neurons revealed the existence 
of an impairment in basal GABAergic transmission 
associated with a normal glutamatergic strength that was 
however remarkably sensitive to depression following high 
frequency stimulation [4]. Subsequent studies performed 
in hippocampal slices, revealed a striking E/I imbalance 
Figure 6: The enhancement of synaptic depression in TKO autaptic neurons is suppressed by GABABR activation. (A) 
Representative eEPSCs evoked by high frequency stimulation (160 stimuli at 8 Hz) in WT and TKO hippocampal autaptic neurons. Pulse 
currents were superimposed to better appreciate synaptic depression. Currents are represented without artifact for clarity. (B-F) Time course 
(left) and quantitative analysis of the percentage of depression (right) in WT (black s) and TKO (red) excitatory autapses under control 
conditions (B) or in the presence of CGP55845 (C), baclofen (D), GABA (E) and GABA+CGP55845 (F). Quantitative analysis was carried 
out by measuring the first eEPSC 0.5 s after the peak of facilitation (Ip) and 5 s after the start of the train stimulation (I5 s), according to 
the formula: (Ip-I5 s)/Ip 
*100 (see panel B). Vehicle (B): WT n=24, TKO n=29; CGP (C): WT n=9, TKO n=9; Bclf (D): WT n=5, TKO n=9; 
GABA (E): WT n=14, TKO n=6; CGP in GABA: WT n=11, TKO n=6. Data were analyzed by unpaired Student’s t-test/Mann-Whitney’s 
U-test; **p<0.01.
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contributed by a decreased inhibitory strength and increased 
excitatory strength [23].
While a primary impairment of inhibitory strength 
was previously reported in Syn I KO neurons [19, 20], 
the increased excitatory strength in synapses depleted of 
SVs was difficult to explain. In this paper, we considered 
the possibility that the hyperactivity of glutamatergic 
transmission is a secondary heterosynaptic result of 
the impairment in inhibitory transmission. Under the 
conditions used to reveal the potentiation of glutamatergic 
synapses, i.e. in the presence of bicuculline [23], the 
decreased drive of fast GABAergic inhibition is not 
involved in this synaptic effect. An alternative possibility 
is represented by an involvement of the inhibitory control 
exerted by metabotropic GABABRs on glutamate release 
at the presynaptic level. GABABRs are located both 
postsynaptically and presynaptically and transduce the 
inhibitory action of GABA through Gβγ-mediated inhibition 
of voltage-gated Ca2+ channels and activation of K+ 
channels that shunt the action potential and further decrease 
Ca2+ influx (see [30, 31] for review). Presynaptic GABABRs 
are often detected extrasynaptically in glutamatergic and, 
to a lesser extent, GABAergic axon terminals [26]. While 
the preferential association of GABABRs with glutamatergic 
synapses suggests an important role in the regulation of 
excitatory synaptic strength, their frequent extrasynaptic 
location makes them a physiologically important target 
also for tonic GABA spillover, in addition to extrasynaptic 
GABAARs [31].
The intracellular signaling linked to GABABRs 
present on glutamatergic terminals is particularly 
critical in the inhibitory control of glutamate release and 
network excitability. The main effect of the stimulation 
of these receptors by endogenous GABA is a decrease of 
presynaptic Ca2+ influx that markedly decreases Pr [27, 
30, 31, 36]. Such decrease in Pr will decrease the number 
of released quanta in response to single action potentials, 
decreasing the eEPSC amplitude and, at the same time, 
enhancing the response to high frequency stimulation by 
favoring facilitation over depression and transforming the 
synapse from a low to a high band-pass activity filter [33, 
37]. In addition to the predominant changes in Pr, we have 
shown that a decreased RRP size also contributes to the 
presynaptic inhibition induced by GABABR activation, in 
agreement with previous findings [28]. The latter effect, 
likely due to decreased SV availability or SV priming, 
may be mediated by the inhibition of adenylyl cyclase 
[27, 38] or by a decreased activation of CaM kinases I/
II during high frequency activity as a consequence of the 
reduced Ca2+ influx [1].
Quantal analysis performed in WT and Syn KO 
autaptic excitatory neurons demonstrated that the low Pr 
and facilitating behavior typical of excitatory synapses 
mostly rely on the presence of a tonic activation of 
GABABRs by extracellular GABA, and that the occupancy 
of presynaptic GABABRs can induce fluctuations in Pr 
from low to high states affecting synaptic strength an short-
term plasticity. We show here that the increased strength 
and propensity for depression observed in excitatory 
synapses of Syn TKO acute hippocampal slices results, 
at least in part, from the lack of presynaptic inhibition by 
GABABRs. In the absence of presynaptic GABAB tone, 
both WT and TKO excitatory synapses experience high 
frequency depression. However, depression is faster and 
more pronounced in TKO synapses, likely because of the 
impaired RRP refilling due to the marked SV depletion 
[4, 39]. However, stimulation of GABABRs in Syn KO 
neurons can completely rescue the depressing phenotype, 
by switching high frequency depression to facilitation and 
overcoming the impairment in the SV supply.
The expression and synaptic responses of 
presynaptic GABABRs are often decreased in the 
hippocampus and cortical areas of epileptic patients (see 
[32] for a recent review). In addition, downregulation of 
presynaptic GABABRs associated with a reduced GABA 
autoinhibition has been observed in several experimental 
models of epilepsy, including hippocampal kindling and 
absence seizures [40-43]. Consistently, GABABR KO 
mice display generalized seizures [44] and GABABR 
antagonists are pro-epileptogenic [45]. Asynchronous 
GABA release, GABA spillover and tonic inhibition 
are known to modulate the input-output behavior of 
single neurons by shunting excitatory currents and 
hyperpolarizing the membrane potential and therefore 
have a protective role in epilepsy [46, 47]. A decrease 
in tonic inhibition was identified in some animal models 
of epilepsy (see [48, 49] for review), including Syn II 
KO and TKO mice [22, 23]. The protective role of tonic 
inhibition from hyperexcitability is further strengthened 
by the tonic stimulation of presynaptic GABABRs by 
extracellular GABA. In fact, stimulation of GABABRs 
is thought to require temporal and spatial summation of 
GABA released by populations of interneurons [50].
It has been reported that a fraction of glutamatergic 
neurons co-release GABA [33, 51]. Although corelease 
of GABA and glutamate is frequently observed in dentate 
gyrus (DG) granule cells projecting to the CA3 region, but 
not in the Schaffer collateral-CA1 synapses, co-released 
GABA by excitatory terminals can participate in the 
GABABR-mediated regulation of excitatory strength and 
short-term plasticity. At the moment, it is not clear whether 
corelease involves distinct pools of SVs with different 
Ca2+ sensitivities, and therefore it is difficult to evaluate 
the impact of Syn deletion on glutamate/GABA corelease. 
However, the decreased extracellular GABA and  tonic 
current observed in hippocampal slices of both TKO mice 
[23] and SynII KO mice [22] indicates that, no matter of 
single release or corelease, glutamatergic and GABAergic 
transmissions are differentially affected by Syn deletion.
These findings, together with the previous data 
on single Syn I and Syn II KO mice, allow depicting 
a hyperexcitability/epileptogenesis pathway in TKO 
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mice. It has been found that lack of Syn I decreases 
synchronous GABA release [19, 20], while lack of Syn 
II markedly impairs asynchronous GABA release [21]. 
It was subsequently demonstrated that both Syn II KO 
and TKO mice have an extremely low tonic current and 
that this current is greatly contributed by the spillover of 
asynchronously released GABA [22, 23]. This primary 
impairment in GABA transmission is followed by an 
increased intrinsic excitability of glutamatergic neurons 
by impairment of phasic inhibition and lack of tonic 
GABAAR-mediated shunting inhibition. However, the 
low extracellular levels of spilled over GABA also leave 
presynaptic GABABRs unoccupied, with a resulting lack 
of the homeostatic presynaptic inhibitory brake on evoked 
glutamate release. These findings allow identifying the 
impairment in GABA release as the primum movens of 
the hyperexcitability of Syn KO mice. Since the extent 
of inhibition provides stability to neuronal networks, 
such imbalance may force neuronal circuits into a state 
of heightened excitability that triggers epileptogenesis, 
resulting in the late (2-3 months of age) appearance 
of the overt epileptic phenotype in mice bearing Syn 
gene deletion [2-5] and in man with loss-of-function 
mutations in SYN genes [15]. A possible pathogenetic 
pathway for the E/I imbalance in TKO neurons and the 
respective contributions of the single Syn gene products 
are schematically shown in Figure 7. The summation of 
the specific effects arising from the lack of Syn I and Syn 
II explain why, even in the absence of redundant functions 
of the two isoforms on neurotransmitter release dynamics, 
the epileptic phenotype of TKO mice is more severe that 
those of single KO mice.
The clarification of the epileptogenic pathway in Syn 
KO mice identifies important targets for pharmacological 
treatments to cure epilepsy in patients bearing SYN 
mutations. According to this interpretation, the combined 
administration of extrasynaptic GABAAR agonists such as 
gaboxadol [22] and GABABR agonists such as baclofen 
should attenuate the E/I imbalance of TKO networks 
by regaining control on both excitability and synaptic 
strength of excitatory neurons. As the E/I imbalance is 
observed well before the onset of seizures, a preventive 
treatment with these drugs not impacting directly on fast 
inhibition could potentially dampen epileptogenesis and 
abort/prevent the resulting epileptic phenotype.
Figure 7: Schematics of the possible pathogenic pathway for the E/I imbalance in Syn TKO neurons. Deletion or loss-of-
function of SYN genes causes a primary impairment of synchronous and asynchronous GABA release due to the defective recruitment and 
priming of SVs. The resulting defect in phasic and tonic inhibition in turn generates E/I imbalance that increases network excitability. At 
the same time, the decreased GABA spillover leaves presynaptic GABABRs unoccupied, resulting in inactivation of the inhibitory brake on 





Homozygous Syn TKO mice [4] were kindly provided 
by Drs. H-T. Kao (Brown University, Providence, RI) and 
Paul Greengard (The Rockefeller University, NY). TKO mice 
were re-derived on a C57BL/6J background (Charles River, 
Calco, Italy), obtaining single and multiple Syn KO strains 
up to the triple Syn knockout (TKO) and matched wild type 
(WT) mice. One-month-old mice of either sex were used. 
All experiments were carried out in accordance with the 
guidelines established by the European Community Council 
(Directive 2010/63/EU of September 22nd, 2010) and were 
approved by the National Council on Health and Animal Care 
(authorization ID 227, prot. 4127 25th March 2008).
Drugs
Bicuculline methiodide (30 μM) and (2R)-
amino-5-phosphonovaleric acid; (2R)-amino-5-
phosphonopentanoate (APV; 100 μM) were applied to 
isolate AMPA receptor-dependent eEPSCs. CGP55845 (5 
μM) or Baclofen (20 μM) was applied to study the effect 
of GABAB receptor blockade/activation. All drugs were 
purchased from Tocris Bioscience (Bristol, UK). Cell 
culture media were from Invitrogen. All other chemicals 
were from Sigma.
Electrophysiology in acute hippocampal slices
Tissue preparation
Hippocampal slices were prepared as previously 
described [23]. Mice were anaesthetized with halothane 
(Sigma-Aldrich, Milan, Italy) and decapitated; the brain 
was quickly removed and immersed in an ice-cold 
“cutting” solution composed of (mM): 125 NaCl, 25 
NaHCO3, 25 glucose, 2.5 KCl, 1.25 NaH2PO4, 1 CaCl2, 
2 MgCl2, 0.4 Ascorbic acid, 2 NaPyruvate, 3 myo-Inositol 
and saturated with 95% O2 and 5% CO2. Horizontal 
hippocampal slices (250 μm-thick) were cut using a HM 
650 vibratome (Microm International GmbH, Walldorf, 
Germany) in ice-cold oxygenated “cutting” solution. 
Slices were first incubated in “cutting” solution at 35 
°C for 30 min and then transferred to a “submerged” 
recording chamber in a “standard recording” solution 
composed of (mM): 125 NaCl, 25 NaHCO3, 25 glucose, 
2.5 KCl, 1.25 NaH2PO4, 2 CaCl2, 1 MgCl2. This solution 
was constantly oxygenated, maintained at 33 °C and 
superfused at a rate of 1.5 ml/min.
Electrophysiological recordings
Whole-cell voltage-clamp recordings from 
CA1 pyramidal neurons of hippocampal slices were 
performed with glass pipettes (~3.8 to 5 MΩ) pulled from 
borosilicate glass (Kimble Glass Inc., Vineland, NJ) and 
filled with the following intracellular solution (mM): 126 
Kgluconate, 4 NaCl, 1 MgSO4, 0.02 CaCl2, 0.1 BAPTA, 
15 glucose, 5 HEPES, 3 ATP, 0.1 GTP. Pyramidal neurons 
of CA1 region of the hippocampus were visualized with 
a 40X water immersion objective and an infrared camera. 
Voltage-clamp recordings were conducted at the holding 
potential of -70 mV and data were acquired using the 
MultiClamp 700B amplifier and the pClamp 9.2 software 
(Axon Instruments, Molecular Devices, Sunnyvale, CA). 
The acquisition frequency was 10 kHz and the filter used 
was 2 kHz; series resistance was monitored throughout 
the experiment and whenever it changed more than 
15%, the recording was not included in the analysis. 
eEPSCs were evoked in pyramidal neurons by electrical 
stimulation of Schaffer collaterals with a bipolar tungsten 
electrode (test pulses at 0.1 Hz, 0.25 ms duration). For 
single pulse responses, the stimulus intensity was varied 
from the lowest intensity able to evoke eEPSCs to an 
intensity eliciting the maximum current amplitude. For 
the short-term plasticity recordings, the stimulation was 
adjusted at intensity able to evoke 2/3 of the maximum 
eEPSC amplitude for synaptic depression and recovery, 
the baseline was evaluated as the mean eEPSC amplitude 
during 5 min of stimulation at 0.1 Hz. The high frequency 
repetitive stimulation protocol (20 Hz for 20 s) was applied 
and followed by lower stimulation frequency (0.1 Hz) to 
evaluate the rate and extent of recovery from synaptic 
depression. Each cell was normalized to the mean baseline 
value and averaged with other cells, electrophysiology in 
hippocampal autapses.
Preparation of hippocampal autaptic cultures
Mice were sacrificed by inhalation of CO2, 
and 17/18-day embryos (E17-E18) were removed 
immediately by cesarean section. Removal and dissection 
of hippocampi were previously described [52]. Briefly, 
hippocampi were dissociated by enzymatic digestion in 
0.125% Trypsin for 20 min at 37 °C and then triturated 
with a fire-polished Pasteur pipette. No antimitotic drugs 
were added to prevent glia proliferation. Autaptic neurons 
were prepared as described previously [35] with slight 
modifications. Dissociated neurons were plated at very 
low density (20 cells/mm2) on microdots (40-300 μm in 
diameter) obtained by spraying a mixture of poly-D-lysine 
(0.1 mg/ml) and collagen (0.25 mg/ml) on dishes that had 
been pretreated with 0.15% agarose. Both glial cells and 
single autaptic neurons were present under this culture 
condition.
Patch-clamp recordings, data acquisition and analysis
Whole-cell patch-clamp recordings were made from 
autaptic neurons grown on microislands, as previously 
described [19, 53]. Patch electrodes, fabricated from thick 
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borosilicate glass (Hilgenberg, Mansfield, Germany), 
were pulled to a final resistance of 3-4 MΩ. eEPSCs were 
recorded using an EPC-10 amplifier (HEKA Electronic, 
Lambrecht, Germany) by superfusing the whole-cell 
clamped neuron with a Tyrode solution containing (in 
mM): 140 NaCl, 2 CaCl2, 1 MgCl2, 4 KCl, 10 glucose,10 
HEPES (pH 7.3 adjusted with NaOH). D-(-)-2-amino-5-
phosphonopentanoic acid (D-AP5; 50 μM; Tocris, Bristol, 
UK) was added to the Tyrode solution to block N-methyl-
D-aspartate receptors, respectively. The standard internal 
solution was (in mM): 126 K gluconate, 4 NaCl, 1 MgSO4, 
0.02 CaCl2, 0.1 BAPTA, 15 glucose, 5 HEPES, 3 ATP, 
0.1 GTP (pH 7.2 adjusted with KOH). All the experiments 
were performed at room temperature. Neurons were 
voltage clamped at -70 mV. Action potentials were evoked 
by depolarizing the cell body to +40 mV for 0.5 ms at 0.1 
Hz. eEPSCs were acquired at 10-20 kHz and filtered at 
one fifth of the acquisition rate with an 8-pole low-pass 
Bessel filter. Recordings with leak currents >100 pA or 
series resistance >10 MΩ were discarded. Data acquisition 
was performed using PatchMaster programs (HEKA 
Elektronic, Lambrecht, Germany). eEPSCs were inspected 
visually, and only those that were not contaminated by 
spontaneous activity were considered. To calculate the 
peak current during an isolated stimulus or a train of 
stimuli, we first subtracted an averaged trace containing 
the stimulus artifact and the action potential current, but 
lacking any discernable synaptic current (i.e. synaptic 
failures). Such traces were easily identified toward the 
end of a train of stimuli, when synaptic depression was 
maximal. These traces were averaged and scaled to the 
peak Na+ current contaminating the eEPSC.
To analyze PPR, two brief supraliminar depolarizing 
pulses were applied to autaptic neurons at 50 ms intervals. 
For each couple of eEPSCs, PPR was calculated as the 
ratio I2/I1, where I1 and I2 are the amplitudes of the eEPSCs 
evoked by the conditioning and test stimuli, respectively. 
The amplitude of I2 was determined as the difference 
between the I2 peak and the corresponding value of I1 
calculated by mono-exponential fitting of the eEPSC 
decay [54]. Because of the high intrinsic variability of 
PPR, the mean PPR was calculated from the responses 
to at least 4-8 paired-pulse stimulation protocols for each 
interpulse interval.
Cumulative eEPSC amplitude analysis
The size of the RRP and Pr were calculated using the 
cumulative amplitude analysis [19]. RRP was determined 
by summing up peak eEPSC amplitudes during 40 
repetitive stimuli applied at 40 Hz. This analysis assumes 
that depression during the steady-state phase is limited 
by a constant recycling of SVs and an equilibrium occurs 
between released and recycled SVs [55, 56]. The number 
of data points for the linear fitting of the steady-state phase 
was evaluated by calculating the best linear fit including 
the maximum number of data points starting from the last 
one (i.e., from the 40th eEPSC). The intercept with the 
Y-axis gave the RRP and the ratio between the amplitude 
of the first eEPSC (I1) and RRP yielded the Pr.
Statistical analysis
Data are expressed as means ± sem for number of 
cells (n). Normal distribution of data was assessed using 
D’Agostino-Pearson’s normality test. The F-test was 
used to compare variance between two sample groups. 
To compare two normally distributed sample groups, the 
Student’s unpaired or paired t-test was used. When two 
sample groups were not normally distributed, the non-
parametric Mann-Whitney’s U-test was used. To compare 
more than two normally distributed sample groups, one-
way ANOVA, followed by post-hoc multiple comparison 
tests was used. Alpha levels for all tests were 0.05% (95% 
confidence intervals). Statistical analysis was carried out 
using OriginPro-8 (OriginLab Corp., Northampton, MA, 
USA) and Prism (GraphPad Software, Inc.) software.
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